ArticleActa parasitologica2026
Seroprevalence of Toxoplasma gondii and Feline Immunodeficiency Virus in Domestic Cats and Their Associations with Clinical Signs.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeFeline immunodeficiency virus (FIV) induces immunosuppression and may predispose cats to opportunistic infections, including Toxoplasma gondii. Data on natural coinfections in domestic cats remain limited, particularly in Europe.
methodsA total of 105 domestic cats from veterinary clinics and shelters in Slovenia and the Czech Republic were examined. Antibodies to T. gondii were detected by Enzyme-Linked Immunosorbent Assay, and FIV antibodies by an immunochromatographic test. Associations with sex, age, housing conditions, and clinical signs were analysed using appropriate statistical tests.
resultsAntibodies to T. gondii were detected in 18.1% of cats, FIV antibodies in 10.5%, and coinfection in 4.8%. T. gondii seropositivity was significantly associated with young age, pet ownership, and the presence of clinical signs. FIV seropositivity was more frequent in males, young cats, pet cats, and clinically affected animals. Coinfection was observed more often in males and pet cats. Cats positive for T. gondii and/or FIV exhibited clinical signs significantly more frequently than seronegative cats (68% vs. 35%, p = 0.0036). Coinfected cats tended to present multiple categories of clinical signs more often than monoinfected cats, although this difference was not statistically significant.
conclusionsThis study provides evidence of associations between host factors, T. gondii and FIV seropositivity, and clinical manifestations in naturally infected cats. Despite limitations related to sample size and serological testing, the findings contribute novel data on T. gondii/FIV coinfection in domestic cats in Central Europe.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.